Pesticide exposure linked to prostate cancer incidence and mortality

Can't see this email? View it online

	Men's Health
	The latest men's health news from News Medical

	Pesticide exposure linked to prostate cancer incidence and mortality Researchers have identified 22 pesticides consistently associated with the incidence of prostate cancer in the United States, with four of the pesticides also linked with prostate cancer mortality. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

	Healthy low-carb diet and time-restricted eating improve weight loss and gut health beyond calorie restriction Researchers discovered that a healthy low-carb diet and time-restricted eating, combined with moderate calorie restriction, offer significant weight loss and gut health benefits for overweight adults, with some effects lasting up to 28 weeks post-intervention.

Study uncovers why white button mushrooms may help prevent prostate cancer progression

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation's top 5 cancer centers by U.S.

	Michigan study finds virtual care does not lead to wastage of healthcare resources Before 2024 ends, Congress will decide whether to keep or change rules about telehealth, or let them expire. And even though the decision will focus on Medicare's payment for virtual patient care, it will likely impact telehealth access for people with other kinds of health insurance too.

	Research shows low vaccination rates for hepatitis A and B in men who have sex with men Research analyzing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance indicates that while most MSM have a basic understanding of viral hepatitis, only 44% report having been vaccinated against both hepatitis A and B.

	Overtreatment of older men with prostate cancer raises concerns Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, according to a new study led by Cedars-Sinai.

	New treatment combination improves outcomes for small cell bladder and prostate cancer patients A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell/neuroendocrine prostate cancer.

	Uncovering novel therapeutic targets in immune checkpoint inhibitor resistance through spatial proteomics in metastatic tumor microenvironments Uncovering novel therapeutic targets in immune checkpoint inhibitor resistance within metastatic tumor microenvironments.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions